Home
Flashcards
Preview
Antiemetic Regimens
Home
Get App
Take Quiz
Create
Carmustine >250mg/m^2
High risk
Cyclophosphamide >/= 1500m^2
High risk
Dacarbazine
High risk
Procarbazine
High risk
Cisplatin
High risk
Cyclophosphamide < 1500m^2 with anthracycline
High risk
Dactinomycin
High risk
Streptozocin
High risk
Aldesleukin >12 - 15 million units/m^2
Moderate risk
Amsacrine
Moderate risk
Arsenic Trioxide
Moderate risk
Azacitadine
Moderate risk
Busulfan > 4mg/day
Moderate risk
Carboplatin
Moderate risk
Carmustine </= 250mg/m^2
Moderate risk
Cyclophosphamide (oral)
Moderate risk
Cyclophosphamide < 1500mg/m^2 without anthracycline
Moderate risk
Cytarabine > 1000mg/m^2
Moderate risk
Daunorubicin
Moderate risk
Doxorubicin
Moderate risk
Epirubicin
Moderate risk
Fotemustine
Moderate risk
Idarubicin
Moderate risk
Ifosfamide
Moderate risk
Imatinib
Moderate risk (however, daily use of antiemetics not recommended based on clinical experience)
Irinotecan
Moderate risk
Lomustine
Moderate risk
Melphalan IV 50mg/m^2
Moderate risk
Methotrexate 250mg/m^2 to 1000mg/m^2
Moderate risk
Oxaliplatin
Moderate risk
Raltitrexed
Moderate risk
Temozolamide
Moderate risk
Vinorelbine
Moderate risk
Bortezomib
Low risk (however, may have >10-30% emetogenic risk in clinical practice - consider treating as moderate risk)
Capecitabine
Low risk
Cetuximab
Low risk
Cytarabine </= 1000mg/m^2
Low risk
Docetaxel
Low risk
Etoposide (IV and oral)
Low risk
Everolimus
Low risk
Methotrexate 50-250mg/m^2
Low risk
Mitomycin C
Low risk
Mitoxantrone
Low risk
Paclitaxel
Low risk
nab-Paclitaxel
Low risk
Panitumumab
Low risk
Pemetrexed
Low risk
Fludarabine (oral)
Low risk
Fluorouracil
Low risk
Gemcitabine
Low risk
Liposomal doxorubicin
Low risk
Sunitinib
Low risk
Temsirolimus
Low risk
Tenoposide
Low risk
Thiotepa
Low risk
Topotecan
Low risk
Alemtuzumab
Minimal risk
Aspariginase-Colaspase
Minimal risk
Bevacizumab
Minimal risk
Bleomycin
Minimal risk
Busulfan </= 4mg
Minimal risk
Chlorambucil
Minimal risk
Cladrabine
Minimal risk
Dasatinib
Minimal risk
Decitabine
Minimal risk
Erlotinib
Minimal risk
Fludarabine (IV)
Minimal risk
Gefitinib
Minimal risk
Gemtuzumab ozogamicin
Minimal risk
Hydroxurea
Minimal risk
Interferon alpha
Minimal risk
Lapatanib
Minimal risk
Lenalidomide
Minimal risk
Melphalan (oral)
Minimal risk
Mercaptopurine
Minimal risk
Methotrexate </= 50mg/m^2
Minimal risk
Methotrexate (oral)
Minimal risk
Rituximab
Minimal risk
Sorafenib
Minimal risk
Thalidomide
Minimal risk
Thioguanine
Minimal risk
Trastuzumab
Minimal risk
Vinblastine
Minimal risk
Vincristine
Minimal risk
Vinorelbine (IV)
Minimal risk
Author
kvan4741
ID
157218
Card Set
Antiemetic Regimens
Description
Recommended antiemetic regimens for chemotheraphy of varying emetogenic risk
Updated
2012-06-04T20:23:00Z
Show Answers
Home
Flashcards
Preview